Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.
Sadr-Nabavi A, Ramser J, Volkmann J, Naehrig J, Wiesmann F, Betz B, Hellebrand H, Engert S, Seitz S, Kreutzfeld R, Sasaki T, Arnold N, Schmutzler R, Kiechle M, Niederacher D, Harbeck N, Dahl E, Meindl A.
Sadr-Nabavi A, et al. Among authors: ramser j.
Int J Cancer. 2009 Apr 1;124(7):1727-35. doi: 10.1002/ijc.24108.
Int J Cancer. 2009.
PMID: 19115204
Free article.